FTC Stalls Omnicare/PharMerica Merger
Antitrust complaint filed against pharmaceutical industry deal.
FHFA Publishes Proposed PACE Rule
Proposed rule may make it harder for homeowners to obtain energy-saving loans.
An Incomplete Contraceptive Coverage Compromise
Despite political assurances, nothing has changed legally in the contraceptive insurance controversy.
Week in Review
CA Proposition 8 struck down, $26 billion foreclosure settlement with banks, contraception mandate debate, and more.
EU Reveals New Strategy to Improve Online Privacy
Proposal would unify EU data protection laws and reduce business compliance costs.
Controversy Surrounds HHS Contraception Mandate
President’s advisers signal willingness to “work with religious groups.”
FDA Submits User-Fee Recommendations to Congress
Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.
YouTube Provides Modified Terms of Service to State Governments
Agreement addresses concern that YouTube’s standard terms of service violate state laws.
Commerce Department Responds to Concerns over Expansion of Internet Domain Names
Public criticism prompts Commerce Department to address risks associated with domain name expansion.
Week in Review
Controversy over insurance coverage for contraception, changes to military family leave policies, highway fund woes and more.
FDA Warns Patients of Stem Cell Scams
The FDA cautions patients to undergo only approved stem cell treatments.
Regulatory Conference Discusses Oversight of Laboratory Developed Tests
Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.